SPINEMarketGroup thespinemarketgroup.com

DeGen Medical Expands Patient-Specific Spine Platform

thespinemarketgroup.com·11h

Boston Scientific Puts $1.5 Billion on MiRus: Why the Spine Market Should Look Beyond TAVR

thespinemarketgroup.com·1d

The ASC Opportunity in Spine Will Be Won by Commercial Redesign, Not by Product Alone

thespinemarketgroup.com·1d

PainTEQ Launches TRAQ™, A Next-Generation Posterior Approach to SI Joint Fusion

thespinemarketgroup.com·4d

Xtant Medical Reports First Quarter 2026 Financial Results

thespinemarketgroup.com·5d

Autonomous Pedicle Screw Placement: Is Spine Robotics Ready for the Next Step?

thespinemarketgroup.com·6d

Medtronic Hits a 52-Week Low: What Is the Market Seeing?

thespinemarketgroup.com·1w

SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon

thespinemarketgroup.com·1w

Cervical Fusion Implant Denials: Why Spine Societies Are Pushing Back

thespinemarketgroup.com·1w

Globus Medical: Strong Q1, Weak Stock Reaction — Is the Market Asking for More?

thespinemarketgroup.com·1w

Globus Medical: Stronger in Spine, but Could DePuy Synthes’ Trauma Business Be the Next Big Move?

thespinemarketgroup.com·1w

Globus Medical Reports First Quarter 2026 Results

thespinemarketgroup.com·1w

Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

thespinemarketgroup.com·1w

Carlsmed® Reports First Quarter 2026 Financial

thespinemarketgroup.com·1w

ATEC Reports First Quarter Financial Results

thespinemarketgroup.com·2w

SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating

thespinemarketgroup.com·2w

Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidanc...

thespinemarketgroup.com·2w

Inhaled Corticosteroids and Lumbar Fusion: A New Revision Risk Signal?

thespinemarketgroup.com·2w

Spineway : First-quarter 2026 revenue

thespinemarketgroup.com·2w

Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

thespinemarketgroup.com·2w

Log in to enable infinite scrolling